Bigul

Unichem Laboratories Ltd - 506690 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayUNICHEM LABORATORIES LTD. 2CININE351A01035 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0 4Highest Credit Rating during the previous FY 0 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Neema Thakore Designation: Company Secretary EmailId: neema.thakore@unichemlabs.com Name of the Chief Financial Officer: Sandip Ghume Designation: Deputy Chief Financial Officer EmailId: sandip.ghume@unichemlabs.com Date: 26/04/2019 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
26-04-2019
Bigul

Unichem Laboratories Ltd - 506690 - Shareholding for the Period Ended March 31, 2019

Unichem Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here
18-04-2019
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Certificate Under Regulation 40(9) & 40 (10) Of The SEBI (LODR) Regulations, 2015 For The Half Year Ended March 31, 2019

Certificate under regulation 40(9) & 40 (10) of the SEBI (LODR) Regulations, 2015 for the half year ended March 31, 2019
18-04-2019
Bigul

Unichem Laboratories Ltd - 506690 - Compliance Certificate For The Period Ended March, 2019

Compliance Certificate For The Period Ended March, 2019
16-04-2019
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Statement Of Investor Complaints For The Quarter Ended March 2019

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Neema ThakoreDesignation :- Company Secretary and Compliance Officer
16-04-2019
Bigul

Unichem Laboratories Ltd - 506690 - Outcome of Board Meeting

Outcome of the Board meeting held on 28.3.2019
28-03-2019
Bigul

Unichem Laboratories Ltd - 506690 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Unichem Laboratories Limited is pleased to announce that it has received final Approval for its ANDA, Tadalafil Tablets, 2.5 mg, 5 mg 10 mg and 20 mg from the United States Food and Drug Administration (USFDA) for a generic version of ELI LILLY's Cialis(r), 2.5 mg, 5 mg, 10 mg and 20 mg.
27-03-2019
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

ANDA approval from USFDA for Unichem's Allopurinol Tablets, USP 100 mg and 300 mg
13-03-2019
Bigul

Unichem Laboratories Ltd - 506690 - Unichem''s Ghaziabad Facility Is Inspected By USFDA

Unichem''s Ghaziabad Facility is inspected by USFDA
11-03-2019
Next Page
Close

Let's Open Free Demat Account